15 results
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
of Weight-Loss Medications ... the FDA for the long-term ... treatment of Obesity ... mg #Obesity #Medications ... Pharmacology #Table #Comparison
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... agents There are ... Each class of medications ... #management #medications ... endocrinology #treatment
Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Overview of various therapies used
bronchoscopic and surgical treatments ... all therapies are ... outcomes or comparison ... to lung volume ... surgery (LVRS) are
Inpatient Management of Opioid Use Disorder: Methadone vs Buprenorphine - Comparison Table

Some patients may decline buprenorphine
Buprenorphine - Comparison ... interested in medication ... assisted treatment ... 7-10 days for long ... common side effects are
Air Bronchograms on Ultrasound

Opacification of alveolar spaces surrounding air-filled bronchioles; enables visualization of well-defined tissue/air interface;
bronchograms (AB) are ... respiration, and are ... Static #Dynamic #POCUS ... #Clinical #Lung ... #Ultrasound #comparison
PDE5 inhibitors are usually the drugs of first choice for erectile dysfunction.

PDE5 inhibitors enhance an erection that is
PDE5 inhibitors are ... #pharmacology #comparison ... #treatment #medications
Atrial Fibrillation RVR - Medications
Diltiazem
 • Preferred in patients with chronic lung such as Asthma and
Fibrillation RVR - Medications ... patients with chronic lung ... with digoxin, are ... #management #treatment ... #comparison #table
Medication overuse headaches or rebound headaches are caused by regular, long-term use of medication to treat headaches, such as migraines.

Treatment of medication overuse
Medication overuse ... rebound headaches are ... caused by regular, long-term ... Treatment of medication ... symptoms #management #treatment
Long-Acting Injectable (LAI) - Atypical Antipsychotics 
INVEGA TRINZA 3 MONTHS 
ARISTADA 2 MONTHS 
INVEGA 1 MONTH
SUSTENNA
Long-Acting Injectable ... antipsychotics, are ... used in the treatment ... Adherence to daily medications ... Pharmacists are
Opioid Use Disorder Medications - Pharmacokinetics

Buprenorphine is a partial mu-opioid receptor agonist with low intrinsic activity,
Opioid Use Disorder Medications ... discontinuation of the medication ... opioid agonists are ... #UseDisorder #Medications ... Pharmacokinetics #Comparison